None patient required platelet transfusion.
所有病人均不需输注血小板。
Objective:To study the reason of refractory of platelet transfusion.
目的：探讨输注血小板无效的原因。
Conclusions: Many factors can induce refractory of platelet transfusion.
结论：引起血小板输注无效的病因复杂。
Objective:To identify the reasons of inefficiency of platelet transfusion.
目的：探讨输注血小板无效的原因。
Objective:To analyze the effect of platelet antibodies on platelet transfusion.
目的：探讨血小板抗体检测对血小板输注效果的影响。
Conclusion UBIT can significantly improve the effective rate of platelet transfusion.
结论血液光量子疗法能显著提高血小板输注有效率。
Conclusion platelet cross matching by MASPAT can improve the efficacy of platelet transfusion.
结论经m ASPAT进行血小板交叉配合试验，能显著提高血小板临床输注效果。
Objective To explore the therapeutic effects of platelet transfusion in acute leukemic patients.
目的探讨急性白血病患者反复输注血小板的治疗效果。
A platelet transfusion may be needed to prevent bleeding if a patient's platelet count is very low.
如果患者血小板数量过低，将有必要为其实施血小板输血以防止流血不止。
Conclusion in this group, the higher the LCT titer, the more likely the ineffective platelet transfusion.
结论发现大多数患者LCT滴度越高，发生血小板输注无效的可能性就越大。
Conclusions: the effect of the fresh platelet transfusion is better than the frozen platelet transfusion.
结论：输注新鲜血小板疗效优于输注深低温保存的血小板。
Conclusion it is suggested that LCT positive is mainly immune factor for ineffective platelet transfusion.
结论研究提示，LCT阳性是造成病人血小板输注无效的主要的免疫性因素。
Objective to explore the relationship between platelet transfusion and LCT in hematologic malignancy patients.
目的探讨恶性血液病患者血小板输注无效与淋巴细胞毒试验(LCT)同种免疫的关系。
Results The isotype platelet antibody was 46.72% in repeated transfusion and concentrated platelet transfusion.
结果多次输血及浓缩血小板造成同种血小板抗体升高达4 6 72 %。
CCI and LCT should be the routine test for platelet patients. It may improve the effects of platelet transfusion.
应将CCI和LCT测算列入反复输注血小板治疗患者的常规检测项目，以期预测CCI和改善血小板输注效果。
Results : The patients subjected to remission-induction chemotherapy had mild to severe bleeding trends , the platelet transfusion rate was 31.5% ;
结果：接受诱导缓解化疗的急性白血病患者，出血倾向轻重不一，输注血小板的比例为31.5%；
This study investigated 112 patients with bone marrow failure needing repeated platelet transfusion. The incidence of induced alloantibody was 53. 6%.
本文探讨了112例骨髓衰竭需长期输血小板的患者，产生同种抗体的比率为53.6%。
Objective: To compare the therapeutic effectiveness of random single donor (SD) platelet transfusion and random multiple donor (MD) platelet transfusion.
目的：探讨输注随机单一供者血小板(SD)与输注随机多供者血小板(MD)疗效的比较。
Donated platelet units should have the white cells removed by filtration prior to transfusion and, if appropriate, should be irradiated as well.
在输注之前应先滤去除捐献血小板中的白细胞，如果有必要，这些血小板还应经过辐照处理。
Objective: To investigate the reasons for ineffective transfusion of single-donor platelet and improve the efficiency of transfusion.
目的：探讨输注单采血小板无效的原因及提高输注的有效率。
The need for surgery or other invasive procedures often requires transfusion to maintain a much higher platelet count during surgery and for a period of healing thereafter.
在实施手术、手术后的愈合及其它创伤性操作时，通常需要输注血小板，以便能够保持一个相对高的血小板计数。
Conclusion: SPISA match and lymphocyte clear can improve the platelet number and reduce the transfusion reaction.
结论：配型和聚脂纤维滤过输注能显著提高患者血小板数目，有效降低输血反应发生率。
Conclusion: SPISA match and lymphocyte clear can improve the platelet number and reduce the transfusion reaction.
结论：配型和聚脂纤维滤过输注能显著提高患者血小板数目，有效降低输血反应发生率。
应用推荐